ASX Announcement MAYNE PHARMA TO PRESENT AT THE 20 TH BIOSHARES SUMMIT 3 August 2026, Adelaide, Australia: Mayne Pharma Group Limited (Mayne Pharma or the Company)(ASX: MYX), today announces an upcoming presentation to the 20 th Bioshares Summit in...
Mayne Pharma to present at the 20th Bioshares Summit
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Earlier from Mayne Pharma
- Mayne Pharma reports unaudited Q4 and FY26 results
- Mayne Pharma receives $14.4m for legal costs from Cosette
- Court awards MYX $13.27m for legal costs from Cosette
- Mayne Pharma reports unaudited 3Q FY26 results
- S&P DJI Announces March 2026 Quarterly Rebalance
Later from Mayne Pharma
- Non-Executive Director appointment
- Notification regarding unquoted securities - MYX
- Notification of cessation of securities - MYX
- Mayne Pharma Bioshares Summit Presentation
- Initial Director's Interest Notice
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma